동맥경화 병태생리 및 치료 효과를 탐지하는 Cathepsin-B 단백분해효소 활성도 광학 분자영상
Molecular Optical Imaging of Cathepsin-B Proteolytic Enzyme Activity to Reflect Atherosclerosis Pathophysiology and Anti-Atherosclerotic Therapeutic Effect
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Protease-sensing molecular optical imaging can potentially identify vulnerable atherosclerotic plaques before cerebral infarcts occur. However, several translational issues need to be resolved before implementing human trials and clinical applications of the technique. We investigated whether molecular optical imaging reflects (1) atherosclerosis pathophysiology and (2) the atherosclerosis-modulating effect of a Western diet or atorvastatin treatment in ApoE-knockout mice. Methods: We fed 21 8-week-old ApoE-knockout mice a normal chow diet (n=7), a Western diet (n=7), or a Western diet with atorvastatin (n=7) for 14 weeks. Blood was collected for measuring cholesterol levels at 24 hours after injecting the cathepsin-B (CatB) probe into the tail vein. Near-infrared fluorescence reflectance imaging of CatB activity was performed after excising the aorta. Results: CatB molecular optical imaging precisely reflected the pathophysiologic alteration of atherosclerosis. The CatB activity signal was significantly stronger in the Western diet group (49.3±26.0 [mean±SD], arbitrary units) than in the atorvastatin group (25.3±8.7) and the normal chow diet group (20.6±21.1). The effect of the statin on CatB activity was independent of cholesterol lowering. Conclusions: CatB-sensing molecular optical imaging represents a valuable tool for evaluating atherosclerosis pathophysiology and for monitoring the effects of antiatherosclerotic therapeutic interventions.
Abstract
Background: Protease-sensing molecular optical imaging can potentially identify vulnerable atherosclerotic plaques before cerebral infarcts occur. However, several translational issues need to be resolved before implementing human trials and clinical applications of the technique. We investigated whether molecular optical imaging reflects (1) atherosclerosis pathophysiology and (2) the atherosclerosis-modulating effect of a Western diet or atorvastatin treatment in ApoE-knockout mice. Methods: We fed 21 8-week-old ApoE-knockout mice a normal chow diet (n=7), a Western diet (n=7), or a Western diet with atorvastatin (n=7) for 14 weeks. Blood was collected for measuring cholesterol levels at 24 hours after injecting the cathepsin-B (CatB) probe into the tail vein. Near-infrared fluorescence reflectance imaging of CatB activity was performed after excising the aorta. Results: CatB molecular optical imaging precisely reflected the pathophysiologic alteration of atherosclerosis. The CatB activity signal was significantly stronger in the Western diet group (49.3±26.0 [mean±SD], arbitrary units) than in the atorvastatin group (25.3±8.7) and the normal chow diet group (20.6±21.1). The effect of the statin on CatB activity was independent of cholesterol lowering. Conclusions: CatB-sensing molecular optical imaging represents a valuable tool for evaluating atherosclerosis pathophysiology and for monitoring the effects of antiatherosclerotic therapeutic interventions.
참고문헌 (21)
- Barnett HJ, "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators", N Engl J Med, 339, pp.1415~1425 (1998)
- Biller J, "Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association", Circulation, 97, pp.501~509 (1998)
- Moore WS, "Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association", Circulation, 91, pp.566~579 (1995)
- Rothwell PM, "Atherothrombosis and ischaemic stroke", BMJ, 334, pp.379~380 (2007)
- Jaffer FA, "Molecular imaging of cardiovascular disease", Circulation, 116, pp.1052~1061 (2007)
- Jaffer FA, "Molecular imaging in the clinical arena", JAMA, 293, pp.855~862 (2005)
- Weissleder R, "Molecular imaging", Radiology, 219, pp.316~333 (2001)
- Deguchi JO, "Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo", Circulation, 114, pp.55~62 (2006)
- Jaffer FA, "Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor", Circulation, 115, pp.2292~2298 (2007)
- Lee S, "A nearinfrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination", Angew Chem Int Ed Engl, 47, pp.2804~2807 (2008)
- Weissleder R, "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes", Nat Biotechnol, 17, pp.375~378 (1999)
- Jaffer FA, "Molecular and cellular imaging of atherosclerosis: emerging applications", J Am Coll Cardiol, 47, pp.1328~1338 (2006)
- Nachtigal P, "MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-", - mouse model of atherosclerosis, 2006, pp.78, 1983~1989
- Wang CY, "Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results", Trends Mol Med, 14, pp.37~44 (2008)
- Aikawa M, "The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach", Cardiovasc Pathol, 13, pp.125~138 (2004)
- Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
- Lusis AJ, "Atherosclerosis", Nature, 407, pp.233~241 (2000)
- Ross R, "Atherosclerosis--an inflammatory disease", N Engl J Med, 340, pp.115~126 (1999)
- Caligiuri G, "Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice", Proc Natl Acad Sci U S A, 96, pp.6920~6924 (1999)
- Henney AM, "Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization", Proc Natl Acad Sci U S A, 88, pp.8154~8158 (1991)
- Libby P, "Molecular determinants of atherosclerotic plaque vulnerability", Ann N Y Acad Sci, 811, pp.134~142 (1997)